Purpose: To evaluate the effects of chalazion excision on the ocular surface, taking into account the subjective symptoms and the objective parameters of the tear film.
Methods: This prospective, interventional clinical study included 52 eyes from 26 patients with eyelid chalazion who underwent excision of the lesions between March and August 2022. Chalazion excision was performed on the patient's chalazion eye, and the contralateral eye served as the control. The following parameters were investigated both preoperatively and 1 week, 1 month, and 3 months postoperatively: the Ocular Surface Disease Index (OSDI), Schirmer I test, corneal fluorescein stain (CFS), tear meniscus height (TMH), noninvasive first breakup time (NifBUT), noninvasive average breakup time (NiaBUT), bulbar conjunctival redness score, the thickness of the lipid layer, and meibomian gland loss.
Results: Before surgery, the OSDI score of the chalazion eye was significantly higher than the contralateral eye. The bulbar conjunctival redness score ( = 0.043) and the OSDI score ( = 0.004) improved significantly in the first month after surgery. In the third month after surgery, the objective parameters showed significant improvements, including TMH ( = 0.032), NiaBUT ( = 0.028), bulbar conjunctival redness score ( < 0.001), the thickness of the lipid layer ( = 0.021), and meibomian gland loss ( = 0.005).
Conclusions: Our study revealed that chalazion excision can significantly improve the subjective symptoms and the objective tear film parameters of the ocular surface.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559556 | PMC |
http://dx.doi.org/10.1016/j.heliyon.2023.e19971 | DOI Listing |
Ophthalmic Plast Reconstr Surg
December 2024
Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, U.S.A.
Purpose: Current treatment approaches aimed at resolving a chalazion vary greatly among practice settings and practitioners. Our objective is to provide a review of existing literature on treatment modalities aimed at resolving a chalazion.
Methods: We conducted a review of existing peer-reviewed publications that described treatment methods aimed at resolving chalazia in patients of any age.
Am J Ophthalmol
January 2025
From the Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children (R.B., A.M.A., K.M., A.A.), Toronto, Ontario, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto (R.B., A.M.A., K.M., A.A.), Toronto, Ontario, Canada. Electronic address:
World J Clin Cases
June 2024
Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou 310006, Zhejiang Province, China.
Dermatopathology (Basel)
April 2024
Postgraduate Program in Dentistry, Department of Dentistry, State University of Paraíba (UEPB), Campina Grande 58429-600, PB, Brazil.
Eur J Ophthalmol
January 2025
Qvision, Opththalmology Department, VITHAS Almería Hospital, Almería, Spain.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!